Your browser doesn't support javascript.
loading
More Than a Gut Feeling─A Combination of Physiologically Driven Dissolution and Pharmacokinetic Modeling as a Tool for Understanding Human Gastric Motility.
Romanski, Michal; Staniszewska, Marcela; Dobosz, Justyna; Myslitska, Daria; Paszkowska, Jadwiga; Kolodziej, Bartosz; Romanova, Svitlana; Banach, Grzegorz; Garbacz, Grzegorz; Sarcevica, Inese; Huh, Yeamin; Purohit, Vivek; McAllister, Mark; Wong, Suet M; Danielak, Dorota.
Affiliation
  • Romanski M; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka St., 60-806 Poznan, Poland.
  • Staniszewska M; Physiolution Polska, 74 Pilsudskiego St., 50-020 Wroclaw, Poland.
  • Dobosz J; Physiolution Polska, 74 Pilsudskiego St., 50-020 Wroclaw, Poland.
  • Myslitska D; Physiolution Polska, 74 Pilsudskiego St., 50-020 Wroclaw, Poland.
  • Paszkowska J; Physiolution Polska, 74 Pilsudskiego St., 50-020 Wroclaw, Poland.
  • Kolodziej B; Physiolution Polska, 74 Pilsudskiego St., 50-020 Wroclaw, Poland.
  • Romanova S; Physiolution Polska, 74 Pilsudskiego St., 50-020 Wroclaw, Poland.
  • Banach G; Physiolution Polska, 74 Pilsudskiego St., 50-020 Wroclaw, Poland.
  • Garbacz G; Physiolution Polska, 74 Pilsudskiego St., 50-020 Wroclaw, Poland.
  • Sarcevica I; Worldwide Research and Development, Pfizer R&D UK Ltd., Sandwich, CT13 9NJ, U.K.
  • Huh Y; Worldwide Research and Development, Pfizer Inc., Groton, Connecticut 06340, United States.
  • Purohit V; Worldwide Research and Development, Pfizer Inc., Groton, Connecticut 06340, United States.
  • McAllister M; Worldwide Research and Development, Pfizer R&D UK Ltd., Sandwich, CT13 9NJ, U.K.
  • Wong SM; Worldwide Research and Development, Pfizer R&D UK Ltd., Sandwich, CT13 9NJ, U.K.
  • Danielak D; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka St., 60-806 Poznan, Poland.
Mol Pharm ; 21(8): 3824-3837, 2024 Aug 05.
Article in En | MEDLINE | ID: mdl-38958668
ABSTRACT
In vivo studies of formulation performance with in vitro and/or in silico simulations are often limited by significant gaps in our knowledge of the interaction between administered dosage forms and the human gastrointestinal tract. This work presents a novel approach for the investigation of gastric motility influence on dosage form performance, by combining biopredictive dissolution tests in an innovative PhysioCell apparatus with mechanistic physiology-based pharmacokinetic modeling. The methodology was based on the pharmacokinetic data from a large (n = 118) cohort of healthy volunteers who ingested a capsule containing a highly soluble and rapidly absorbed drug under fasted conditions. The developed dissolution tests included biorelevant media, varied fluid flows, and mechanical stress events of physiological timing and intensity. The dissolution results were used as inputs for pharmacokinetic modeling that led to the deduction of five patterns of gastric motility and their prevalence in the studied population. As these patterns significantly influenced the observed pharmacokinetic profiles, the proposed methodology is potentially useful to other in vitro-in vivo predictions involving immediate-release oral dosage forms.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Solubility / Gastrointestinal Motility Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Solubility / Gastrointestinal Motility Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: